Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NQ:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Top News
More News
Hollis-Eden Pharma (HEPH) Announces Name Change to Harbor Biosciences, Ticker to 'HRBR'
February 17, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5359578 for the full story.
Read More
from
StreetInsider.com News Articles
Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR'
February 17, 2010
from
PR Newswire
More News
Read More
Letter up 230% last year without trading
January 11, 2010
category
Market News
,
DYAI
,
Opinion
, and 12 more.
from
MarketWatch
After-Hours Movers 12/22: FINL, RHT, FSII, MU Higher; APFC, CTAS, HEPH Lower
December 22, 2009
from
StreetInsider.com News Articles
Hollis-Eden Pharma (HEPH) Files $75M Mixed Shelf
December 22, 2009
from
StreetInsider.com News Articles
Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular Targets and Cancer Therapeutics Conference
November 16, 2009
from
PR Newswire
Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer Therapeutics Conference
November 12, 2009
from
PR Newswire
Hollis-Eden Pharmaceuticals Retains Burrill LLC to Provide Exclusive Advisory Services for Lead Programs
October 20, 2009
from
PR Newswire
Hollis-Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid Price
September 16, 2009
from
PR Newswire
Drug stocks edge higher; Genzyme falls
June 16, 2009
category
Biotechnology
,
GENZ
,
$DRG
, and 7 more.
from
MarketWatch
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here